Sandra Beare

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Paul Hoskins, Elizabeth A. Eisenhauer, Sandra Beare et al. · Journal of Clinical Oncology · 1998 · 172 citations

A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study

John Bridgewater, Andre Lopes, Sandra Beare et al. · BMC Cancer · 2016 · 71 citations · Full text

GeDDiS: A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29).

Beatrice Seddon, Jeremy Whelan, Sandra J. Strauss et al. · Journal of Clinical Oncology · 2015 · 59 citations

Surgical Oncology, Oncology, Malignant Disease +15

Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU in squamous cell carcinoma of the anus: Results of ACT II.

Rob Glynne‐Jones, R.D. James, Helen Meadows et al. · Journal of Clinical Oncology · 2012 · 43 citations

Surgical Oncology, Squamous Cell Carcinoma, Cancer Management +17

Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study

Michael Crump, Jeffrey H. Lipton, David W. Hedley et al. · Leukemia · 1999 · 39 citations

Hematological Malignancy, National Cancer Institute, Medicine +9